Fund Holdings — Atlas Venture Life Science Advisors, LLC

Total Portfolio Value
$752.64M
Total Bought
$3.08M
Total Sold
$169.57M
Net Transaction
-$166.49M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q2 2025
▲▼
Q3 2025
▲▼
Change
▲▼
Q2 2025
▲▼
Q3 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Kymera Therapeutics, Inc.(KYMR)4,896,4624,896,4620213,682277,14036.82%+63,458
Sionna Therapeutics, Inc.(SION)3,694,0203,615,527-78,49364,091106,33314.13%+42,241
Korro Bio, Inc.(KRRO)1,137,1491,137,149014,20354,4587.24%+40,255
Dyne Therapeutics, Inc.(DYN)9,130,4659,130,465086,922115,50015.35%+28,578
Disc Medicine, Inc.(IRON)2,384,4562,142,617-241,839126,281141,58418.81%+15,303
Day One Biopharmaceuticals, Inc.
COM
6,430,2576,430,257041,79745,3336.02%+3,537
ImageneBio, Inc.(IMA)0377,814+377,81403,0790.41%+3,079
Generation Bio, Co.8,279,484827,946-7,451,5382,6505,0670.67%+2,417
Q32 Bio, Inc.(FIXX)2,092,1062,092,10603,1174,1420.55%+1,025
Ikena Oncology, Inc.5,018,1780-5,018,1786,7240—-6,724
Vigil Neuroscience, Inc.5,836,8740-5,836,87446,4030—-46,403
Third Harmonic Bio, Inc.10,402,2860-10,402,28656,4840—-56,484
Page 1 of 1
Atlas Venture Life Science Advisors, LLC — 13F Holdings — Q3 2025 | TickerTrail